4.7 Article

AKAP1 Protects from Cerebral Ischemic Stroke by Inhibiting Drp1-Dependent Mitochondrial Fission

Journal

JOURNAL OF NEUROSCIENCE
Volume 38, Issue 38, Pages 8233-8242

Publisher

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.0649-18.2018

Keywords

ischemia; mitochondria; mitochondrial fission; neuroprotection; protein kinase; protein phosphorylation

Categories

Funding

  1. Roy J. Carver Charitable Trust
  2. Iowa Neuroscience Institute
  3. National Institutes of Health [NS056244, NS087908, NS087068, NS096246, DK54441, GM32875]
  4. American Heart Association (AHA) [HL118246, HL118742, 18EIA33900009]
  5. AHA postdoctoral fellowship [14POST20480080]
  6. Carver College of Medicine: Genomics Division
  7. Carver College of Medicine: Viral Vector Core
  8. Carver College of Medicine: Central Microscopy Core

Ask authors/readers for more resources

Mitochondrial fission and fusion impact numerous cellular functions and neurons are particularly sensitive to perturbations in mitochondrial dynamics. Here we describe that male mice lacking the mitochondrial A-kinase anchoring protein 1 (AKAP1) exhibit increased sensitivity in the transient middle cerebral artery occlusion model of focal ischemia. At the ultrastructural level, AKAP1(-/-) mice have smaller mitochondria and increased contacts between mitochondria and the endoplasmic reticulum in the brain. Mechanistically, deletion of AKAP1 dysregulates complex II of the electron transport chain, increases superoxide production, and impairs Ca2+ homeo-stasis in neurons subjected to excitotoxic glutamate. Ca2+ deregulation in neurons lacking AKAP1 can be attributed to loss of inhibitory phosphorylation of the mitochondrial fission enzyme dynamin-related protein 1 (Drp1) at the protein kinase A (PKA) site Ser637. Our results indicate that inhibition of Drp1-dependent mitochondrial fission by the outer mitochondrial AKAP1/PKA complex protects neurons from ischemic stroke by maintaining respiratory chain activity, inhibiting superoxide production, and delaying Ca2+ deregulation. They also provide the first genetic evidence that Drp1 inhibition may be of therapeutic relevance for the treatment of stroke and neurodegeneration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available